Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Insider trades › Bio-Rad Laboratories › Officer exercised or converted 1,027 BIO derivative securities Insider trades
Why it stands out Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Transaction date Sep 5, 2026
Reporting period Not applicable
Filed with the SEC Sep 9, 2026 Officer Option exercise
Context Classification option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID 0002022345-26-000004
Filed / recorded
Sep 9, 2026, 10:46 PM UTC
Added to OQRO Oct 6, 2026, 4:40 PM UTC
Data quality Verified: identifiers matched exactly
Issuer BIO-RAD LABORATORIES, INC.
Reporting person James Barry
Officer title EVP, President, LSG
Security Restricted Stock Units
Table Derivative (Table II)
Transaction date Sep 5, 2026
Acquired / disposed Disposed (D)
Footnotes from the filing Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
Around the same time Insider filing
Traded Sep 5 · filed 4 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Sep 5 · filed 4 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Sep 6 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Jul 31, 2026 Company filing · Form 8-K · Results, Restructuring Announced job cuts, closures or a restructuring, and reported its results (and 1 more item) “On July 31, 2026, Bio-Rad Laboratories, Inc. (the “ Company ") initiated a strategy-driven restructuring plan as part of our ongoing program to improve operating performance and strengthen the Company’s competitive position.” What came next Nov 4, 2026 Company filing · Form 8-K · Results, Reg FD Reported its results, and shared information with investors Nov 9, 2026 Insider · 2 people Insiders: 2 sales (~$899K) Nov 10, 2026 Insider Officer sold ~$348K of BIO shares in the open market